FI924215A - Anvaendningen av il-4 foer oekning av immunreaktionen foerorsakad infektiosa antigen aemnen - Google Patents

Anvaendningen av il-4 foer oekning av immunreaktionen foerorsakad infektiosa antigen aemnen Download PDF

Info

Publication number
FI924215A
FI924215A FI924215A FI924215A FI924215A FI 924215 A FI924215 A FI 924215A FI 924215 A FI924215 A FI 924215A FI 924215 A FI924215 A FI 924215A FI 924215 A FI924215 A FI 924215A
Authority
FI
Finland
Prior art keywords
agents
aemnen
conduct
inducing
immune response
Prior art date
Application number
FI924215A
Other languages
English (en)
Other versions
FI924215A0 (fi
Inventor
Jerome Schwartz
Claude H Nash
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI924215A publication Critical patent/FI924215A/fi
Publication of FI924215A0 publication Critical patent/FI924215A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI924215A 1990-03-21 1992-09-21 Anvaendningen av il-4 foer oekning av immunreaktionen foerorsakad infektiosa antigen aemnen. FI924215A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49683290A 1990-03-21 1990-03-21
PCT/US1991/001733 WO1991014450A1 (en) 1990-03-21 1991-03-19 Use of il-4 to enhance immune response to infectious antigenic challenges

Publications (2)

Publication Number Publication Date
FI924215A true FI924215A (fi) 1992-09-21
FI924215A0 FI924215A0 (fi) 1992-09-21

Family

ID=23974340

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924215A FI924215A0 (fi) 1990-03-21 1992-09-21 Anvaendningen av il-4 foer oekning av immunreaktionen foerorsakad infektiosa antigen aemnen.

Country Status (19)

Country Link
EP (1) EP0521916B1 (fi)
JP (1) JPH05505799A (fi)
CN (1) CN1055116A (fi)
AT (1) ATE133074T1 (fi)
AU (1) AU656889B2 (fi)
CA (1) CA2078676A1 (fi)
DE (1) DE69116552T2 (fi)
DK (1) DK0521916T3 (fi)
ES (1) ES2082201T3 (fi)
FI (1) FI924215A0 (fi)
GR (1) GR3019018T3 (fi)
HU (1) HUT63062A (fi)
IE (1) IE72204B1 (fi)
IL (1) IL97600A0 (fi)
MY (1) MY108672A (fi)
OA (1) OA09672A (fi)
PT (1) PT97082B (fi)
WO (1) WO1991014450A1 (fi)
ZA (1) ZA912037B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100191223B1 (ko) * 1989-07-28 1999-06-15 둘락 노먼 씨. 인터루킨-4의 정제방법 및 이를 함유하는 약제학적 조성물
US5827670A (en) * 1990-08-02 1998-10-27 Fred Hutchinson Cancer Research Center Methods of isolating and detecting bone marrow stromal cells with VCAM-1-specific antibodies
US7449186B1 (en) 1990-08-02 2008-11-11 Fred Hutchinson Cancer Research Center Methods of blocking the interaction between stromal cells and hemopoietic cells with anti-VCAM-1 antibodies
AU9161591A (en) * 1990-12-19 1992-07-22 Schering Corporation Use of il-4 to enhance immune response to immunogens in vaccines
DE69209051T2 (de) * 1991-01-10 1996-08-08 Schering Corp Verwendung von il-4 zur verstärkung von wundheilung und besserung und zur heilung von infizierten wunden und wunden bei diabetischen säugetieren
GB9124347D0 (en) * 1991-11-15 1992-01-08 Isis Innovation Treatment of macrophages
US5700461A (en) * 1992-08-19 1997-12-23 Schering Corporation Method for inhibiting HIV replication using IL-4

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT83761B (pt) * 1985-11-19 1989-06-30 Schering Biotech Corp Metodo para a producao de interleuquina-4 de mamifero
EP0302429B1 (en) * 1987-08-03 1993-07-28 Tasuku Honjo Novel human interleukin 4, expression vectors for human interleukin 4 and transformants containing the same
JPH0236129A (ja) * 1988-07-22 1990-02-06 Ajinomoto Co Inc ワクチン効果増強剤
JPH0611706B2 (ja) * 1989-01-20 1994-02-16 ザ ユニバーシティ オブ メルボルン フィブリン溶解

Also Published As

Publication number Publication date
AU656889B2 (en) 1995-02-23
MY108672A (en) 1996-10-31
PT97082A (pt) 1991-11-29
DE69116552T2 (de) 1996-05-30
FI924215A0 (fi) 1992-09-21
HUT63062A (en) 1993-07-28
EP0521916A1 (en) 1993-01-13
WO1991014450A1 (en) 1991-10-03
DK0521916T3 (da) 1996-03-04
ATE133074T1 (de) 1996-02-15
CA2078676A1 (en) 1991-09-22
IL97600A0 (en) 1992-06-21
ZA912037B (en) 1992-03-25
PT97082B (pt) 1998-07-31
IE72204B1 (en) 1997-04-09
DE69116552D1 (de) 1996-02-29
IE910921A1 (en) 1991-09-25
EP0521916B1 (en) 1996-01-17
GR3019018T3 (en) 1996-05-31
CN1055116A (zh) 1991-10-09
JPH05505799A (ja) 1993-08-26
AU7469091A (en) 1991-10-21
OA09672A (en) 1993-05-15
ES2082201T3 (es) 1996-03-16

Similar Documents

Publication Publication Date Title
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
MX9304089A (es) Uso de gm-csf como una vacuna adyuvante.
ATE157257T1 (de) Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
IL87621A0 (en) Conjugates of cytokines with immunoglobulins,their preparation and pharmaceutical compositions containing them
NO821832L (no) Fremgangsmaate for fremstilling av allergenholdige kapsler
DE69130071T2 (de) Zusammensetzung verwendbar als therapeutisches mittel gegen chronische virale leberkrankheiten
DE3669106D1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
DE60040740D1 (de) VERWENDUNG OF INTERLEUkIN-1 MUTEIN ALS IMPFSTOFFADJUVANS
FI924215A (fi) Anvaendningen av il-4 foer oekning av immunreaktionen foerorsakad infektiosa antigen aemnen
ES2118087T3 (es) Composiciones inmunosupresoras.
ATE67783T1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
DK0563254T3 (da) Anvendelse af IL-4 til forstærkning af immunrespons på immunogener i vacciner
ATE229981T1 (de) Glykolisierte cytokine
KR960700741A (ko) 인터페론치료에 대한 무응답자의 c형 간염 치료방법(method of treating hepatitis c in non-pesponders to interferon treatment)
FI981624A (fi) Koostumukset ja menetelmät Borrelia burgdorferi antigeenien annostelemiseksi
DE69706657D1 (de) Natürliches menschliches alpha interferon enthaltende pharmazeutische zusammensetzungen
DE3879837T2 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
ATE64855T1 (de) Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.

Legal Events

Date Code Title Description
FD Application lapsed